超声乳化白内障吸除术对糖尿病白内障角膜内皮细胞影响的研究

doi:10.3760/cma.j.issn.1007-1245.2024.21.008

摘要/Abstract

摘要：

糖尿病性白内障是造成糖尿病患者视力下降和失明的主要原因。超声乳化白内障吸除术（Phaco）是临床治疗白内障的常见手段。糖尿病和Phaco是导致角膜内皮细胞损伤的危险因素，通过保护糖尿病患者术前、术中与术后的角膜内皮细胞，可有效减轻Phaco对角膜内皮细胞的损害。本文综述糖尿病和Phaco对角膜内皮细胞的影响及可能机制，以及在Phaco术前、术中与术后对糖尿病患者角膜内皮细胞的保护措施。

关键词:

超声乳化白内障吸除术, 糖尿病, 白内障, 角膜内皮细胞, 进展

Abstract:

Diabetic cataract is one of the leading causes of vision loss and blindness in diabetic patients. Phacoemulsification is a common clinical treatment for cataracts. Both diabetes and phacoemulsification are risk factors for corneal endothelial cell damage. Corneal endothelial cell damage by phacoemulsification can be effectively mitigated by protecting corneal endothelial cells in diabetic patients before, during, and after surgery. This article reviews the effects and possible mechanisms of diabetes and phacoemulsification on corneal endothelial cells, as well as measures to protect corneal endothelial cells in diabetic patients before, during, and after phacoemulsification.

Key words:

Phacoemulsification, Diabetes, Cataract, Corneal endothelial cells, Progress

黄菊李诗怡张澳王康张培培谢迎宾.

超声乳化白内障吸除术对糖尿病白内障角膜内皮细胞影响的研究 [J]. 国际医药卫生导报, 2024, 30(21): 3558-3564.

Huang Ju, Li Shiyi, Zhang Ao, Wang Kang, Zhang Peipei, Xie Yingbin.

Research progress on effect of phacoemulsification on corneal endothelial cells in patients with diabetic cataract [J]. International Medicine and Health Guidance News, 2024, 30(21): 3558-3564.

参考文献

[1] 张波,杨文英. 中国糖尿病流行病学及预防展望[J]. 中华糖尿病杂志,2019,11(1):7-10.DOI:10.3760/cma.j.issn. 1674-5809.2019.01.002.
[2] American Diabetes Association. Diagnosis and classification of diabetes mellitus[J]. Diabetes Care,2014,37 Suppl 1:S81-S90.DOI:10.2337/dc14-S081.
[3] 涂娜,汪婧媛. 糖尿病患者罹患白内障的相关影响因素分析[J]. 医疗装备,2023,36(2):79-81.DOI:10.3969/j.issn.1002-2376.2023.02.024.
[4] 张敬超,范小霞,王红娟. 金华市50岁及以上2型糖尿病患者白内障患病状况及影响因素分析[J]. 实用预防医学,2023,30(12):1476-1480.DOI:10.3969/j.issn.1006-3110. 2023.12.015.
[5] Goldstein AS, Janson BJ, Skeie JM, et al. The effects of diabetes mellitus on the corneal endothelium: a review[J].Surv Ophthalmol,2020,65(4):438-450.DOI:10.1016/j.survophthal.2019.12.009.
[6] 胡芷馨,肖宇婷,刘欣,等. 角膜内皮细胞治疗研究进展[J]. 眼科新进展,2021,41(11):1097-1100.DOI:10.13389/j.cnki.rao.2021.0230.
[7] 阮余霞. 高糖环境对兔角膜内皮细胞的影响[D].广州:暨南大学,2011.
[8] Chen C, Zhang B, Xue J, et al. Pathogenic role of endoplasmic reticulum stress in diabetic corneal endothelial dysfunction[J].Invest Ophthalmol Vis Sci,2022,63(3):4.DOI:10.1167/iovs.63.3.4.
[9] 黄钰清,杨燕宁. 氧化应激在糖尿病性角膜病变中的研究进展[J]. 国际眼科杂志,2022,22(3):399-402.DOI:10.3980/j.issn.1672-5123.2022.3.09.
[10] Takahashi H. Corneal endothelium and phacoemulsification[J].Cornea,2016,Suppl 1:S3-S7.DOI:10.1097/ICO.0000000000000990.
[11] Xie L, Fang H, Xie Y, et al. Corneal endothelial characteristics in normal Chinese han children and youngsters: a study from the specular microscopy descriptions[J].Dis Markers,2022,2022:5338725.DOI:10.1155/2022/5338725.
[12] 蒋璐. 2型糖尿病患者角膜厚度和角膜内皮细胞形态学相关研究[D]. 银川:宁夏医科大学,2020.DOI:10.27258/d.cnki.gnxyc.2020.000099.
[13] Taşlı NG, Icel E, Karakurt Y, et al. The findings of corneal specular microscopy in patients with type-2 diabetes mellitus[J].BMC Ophthalmol,2020,20(1):214.DOI:10.1186/s12886-020-01488-9.
[14] Chowdhury B, Bhadra S, Mittal P, et al. Corneal endothelial morphology and central corneal thickness in type 2 diabetes mellitus patients[J].Indian J Ophthalmol,2021,69(7):1718-1724.DOI:10.4103/ijo.IJO_3120_20.
[15] El-Agamy A, Alsubaie S. Corneal endothelium and central corneal thickness changes in type 2 diabetes mellitus[J].Clin Ophthalmol,2017,11:481-486.DOI:10.2147/OPTH.S126217.
[16] Beato JN, Esteves-Leandro J, Reis D, et al. Evaluation of corneal structure and endothelial morphological characteristics in type 2 diabetic and non-diabetic patients[J].Clin Ophthalmol,2020,14:1993-1999.DOI:10.2147/OPTH.S256244.
[17] 廖丹凌. Ⅱ型糖尿病患者角膜内皮改变及相关危险因素的分析[D]. 福州:福建医科大学,2021.
[18] 陈妍鹏,仝真真,李毅. 2型糖尿病病人眼前段生物测量值的变化及临床意义[J]. 安徽医药,2023,27(8):1586-1590.DOI:10.3969/j.issn.1009-6469.2023.08.021.
[19] Briggs S, Osuagwu UL, AlHarthi EM. Manifestations of type 2 diabetes in corneal endothelial cell density, corneal thickness and intraocular pressure[J].J Biomed Res,2015,8;30.DOI:10.7555/JBR.29.20140075.
[20] 陈素芸,周臣敏. 糖化血红蛋白检测在糖尿病诊断中的临床意义[J]. 检验医学与临床,2017,14(5):640-642.DOI:10.3969/j.issn.1672-9455.2017.05.015.
[21] Çolak S, Kazanci B, Ozçelik Soba D, et al. Effects of diabetes duration and HgA1C level on corneal endothelial morphology[J].Eur J Ophthalmol,2021,31(3):967-975.DOI:10.1177/1120672120914812.
[22] 翁彦颖. 不同糖化血红蛋白水平与2型糖尿病患者眼前节参数的相关性研究[D]. 福州:福建医科大学,2019.
[23] 覃水喷. 糖尿病视网膜病变的临床治疗现状及研究进展[J]. 国际医药卫生导报,2022,28(8):1180-1184.DOI:10.3760/cma.j.issn.1007-1245.2022.08.035.
[24] Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review[J].Clin Exp Ophthalmol,2016,44(4):260-277.DOI:10.1111/ceo.12696.
[25] Wilkinson CP, Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales[J].Ophthalmology,2003,110(9):1677-1682.DOI:10.1016/S0161-6420(03)00475-5.
[26] 何香莲,王政来,王少林. 糖尿病视网膜病变不同时期角膜神经纤维和细胞结构损害的研究[J]. 宁夏医学杂志,2023,45(3):262-264.DOI:10.13621/j.1001-5949.2023.03.0262.
[27] Mortazavi SA, Akhlaghi M, Dehghani A, et al. Diabetic retinopathy and corneal endothelial parameters: an analytical cross-sectional study[J].BMC Ophthalmol,2022,22(1):427. DOI:10.1186/s12886-022-02667-6.
[28] Samsu N. Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment[J].Biomed Res Int,2021,2021:1497449.DOI:10.1155/2021/1497449.
[29] Lee CM, Afshari NA. The global state of cataract blindness[J].Curr Opin Ophthalmol,2017,28(1):98-103.DOI:10.1097/ICU.0000000000000340.
[30] 杭丽. 接受白内障超声乳化术的患者术中及术后出现并发症的原因及应对措施[J]. 当代医药论丛,2017,15(24):84-85.DOI:10.3969/j.issn.2095-7629.2017.24.057.
[31] 张磊. 白内障超声乳化对角膜内皮的临床观察[J]. 中国继续医学教育,2019,11(17):99-101.DOI:10.3969/j.issn. 1674-9308.2019.17.044.
[32] Chang VS, Gibbons A, Osigian C. Phacoemulsification in the setting of corneal endotheliopathies: a review[J].Int Ophthalmol Clin,2020,60(3):71-89.DOI:10.1097/IIO.0000000000000315.
[33] Shimazaki J, Amano S, Uno T, et al. National survey on bullous keratopathy in Japan[J].Cornea,2007,26(3):274-278.DOI:10.1097/ICO.0b013e31802c9e19.
[34] Kunzmann BC, Wenzel DA, Bartz-Schmidt KU, et al. Effects of ultrasound energy on the porcine corneal endothelium - establishment of a phacoemulsification damage model[J].Acta Ophthalmol,2020,98(2):e155-e160.DOI:10.1111/aos.14235.
[35] Bamdad S, Bolkheir A, Sedaghat MR, et al. Changes in corneal thickness and corneal endothelial cell density after phacoemulsification cataract surgery: a double-blind randomized trial[J].Electron Physician,2018,10(4):6616-6623.DOI:10.19082/6616.
[36] 张昌富,王雪林,苏文华,等. 超声乳化手术中灌注压对糖尿病白内障患者角膜内皮的影响研究[J]. 中国医学创新,2021,18(35):135-139.DOI:10.3969/j.issn.1674-4985. 2021.35.033.
[37] 王俊,甘孟欣,黄桦. 超声乳化术导致角膜内皮细胞损伤的危险因素分析[J]. 中国辐射卫生,2022,31(4):498-501.DOI:10.13491/j.issn.1004-714X.2022.04.022.
[38] Chen K, Xu WY, Sun SS, et al. Corneal endothelial cells and acoustic cavitation in phacoemulsification[J].World J Clin Cases,2023,11(8):1712-1718.DOI:10.12998/wjcc.v11.i8.1712.
[39] 胡文静,高凡. 白内障患者超声乳化吸除联合人工晶状体植入术后发生角膜水肿的危险因素分析[J]. 贵州医药,2022,46(11):1775-1776.DOI:10.3969/j.issn.1000- 744X. 2022.11.056.
[40] Buschschlüter S, von Eicken J, Wilhelm U, et al. The relationship between the temperature increase caused by phacoemulsification and the damage to the corneal endothelium[J].Klin Monbl Augenheilkd,2014,231(8):822-829.DOI:10.1055/s-0034-1382848.
[41] Ciorba AL, Roiu G, Abdelhamid AM, et al. Evaluation of the corneal endothelium following cataract surgery in diabetic and non-diabetic patients[J].Diagnostics (Basel),2023,13(6):1115.DOI:10.3390/diagnostics13061115.
[42] Yang Y, Chai H, Ding Z, et al. Meta-analysis of corneal endothelial changes after phacoemulsification in diabetic and non-diabetic patients[J].BMC Ophthalmol,2023,23(1):174.DOI:10.1186/s12886-023-02924-2.
[43] 邹捷敏,李娴,孙建华. HbA1c水平对糖尿病患者白内障超声乳化术后角膜内皮细胞的影响[J]. 中国卫生标准管理,2018,9(3):37-39.DOI:10.3969/j.issn.1674-9316. 2018.03.019.
[44] 陈伟金,蓝恋华. 探讨糖化血红蛋白在糖尿病患者白内障术后的应用价值[J]. 糖尿病新世界,2022,25(7):50-53,66.DOI:10.16658/j.cnki.1672-4062.2022.07.050.
[45] 杨颖秋,李永蓉. 糖尿病患者白内障超声乳化摘除联合人工晶体植入术后角膜内皮细胞形态学研究[J]. 实用防盲技术,2023,18(2):65-68,72.DOI:10.3969/j.issn.1673-3835. 2023.02.007.
[46] Lin Y, Zhou B, Yao Y, et al. Clinical observation of phacoemulsification under the low perfusion pattern and low negative pressure in patients with low corneal endothelial cell density[J].BMC Ophthalmol,2023,23(1):340.DOI:10.1186/s12886-023-03095-w.
[47] 郭小博,李建伟. 白内障患者超声乳化人工晶体植入术对角膜内皮细胞损伤的危险因素研究[J]. 贵州医药,2020,44(12):1892-1893.DOI:10.3969/j.issn.1000- 744X. 2020.12.021.
[48] 孙岩秀,杨志钢,王薇. 数字微脉冲超声乳化术后角膜内皮的变化[J]. 眼外伤职业眼病杂志,2005,27(3):170-171.DOI:10.3760/cma.j.issn.2095-1477.2005.03.004.
[49] Jing Z, Hao J, Sun L, et al. Analysis of influencing factors of corneal edema after phacoemulsification for diabetic cataract[J].Cell Mol Biol (Noisy-le-grand),2023,69(4):164-171.DOI:10.14715/cmb/2023.69.4.26.
[50] 张红言,孙璐,宋旭东,等. 两种黏弹剂及超声乳化时间对超声乳化白内障吸除联合人工晶状体植入术患者角膜内皮细胞及角膜厚度影响的临床研究[J/CD]. 中华眼科医学杂志(电子版),2020,10(6):357-362.DOI:10.3877/cma.j.issn.2095-2007.2020.06.007.
[51] 韩慧. 飞秒激光辅助白内障手术和传统超声乳化白内障手术在糖尿病白内障中的对比研究[D]. 杭州:浙江大学,2021.
[52] 李文博,贾烨,李杨林,等. 不同黏弹剂对白内障超乳摘除及折叠IOL植入术后患者角膜内皮的影响[J]. 国际眼科杂志,2022,22(10):1727-1730.DOI:10.3980/j.issn.1672-5123. 2022.10.26.
[53] 刘奕志,蒋宇振. 软壳技术[J]. 中华眼科杂志,2005,41(7):667-669.DOI:10.3760/j:issn:0412-4081.2005.07.022.
[54] 杨玲,屈政朋. 软壳技术在白内障超声乳化术中的应用效果[J]. 中国当代医药,2019,26(8):138-140.DOI:10.3969/j.issn.1674-4721.2019.08.044.
[55] Nemet AY, Assia EI, Meyerstein D, et al. Protective effect of free-radical scavengers on corneal endothelial damage in phacoemulsification[J].J Cataract Refract Surg,2007,33(2):310-315.DOI:10.1016/j.jcrs.2006.10.031.
[56] M Padua IR, P Valdetaro G, B Lima T, et al. Effects of intracameral ascorbic acid on the corneal endothelium of dogs undergoing phacoemulsification[J].Vet Ophthalmol,2018,21(2):151-159.DOI:10.1111/vop.12490.
[57] 李翔,毛肖丽. 同轴1.8mm微切口超声乳化治疗合并糖尿病的白内障[J]. 国际眼科杂志,2020,20(1):111-114.DOI:10.3980/j.issn.1672-5123.2020.1.25.
[58] 毛景璟,彭坤,陈林勇. 两种不同切口方式治疗白内障合并2型糖尿病患者在超声乳化术中的应用比较[J]. 浙江创伤外科,2023,28(8):1494-1496.DOI:10.3969/j.issn.1009- 7147. 2023.08.029.
[59] 钟祥兰. 不同切口超声乳化人工晶体植入术治疗白内障患者的临床效果[J]. 医疗装备,2023,36(12):97-99.DOI:10.3969/j.issn.1002-2376.2023.12.031.
[60] 黄兆敏,侯正玉,李盈龙,等. 两种不同切口下的白内障超声乳化术对角膜内皮细胞的影响[J]. 临床眼科杂志,2023,31(2):151-153.DOI:10.3969/j.issn.1006-8422. 2023.02.012.
[61] Hoppenreijs VP, Pels E, Vrensen GF, et al. Basic fibroblast growth factor stimulates corneal endothelial cell growth and endothelial wound healing of human corneas[J].Invest Ophthalmol Vis Sci,1994,35(3):931-944.
[62] Su CC, Ho WT, Peng FT, et al. Exploring a peptidomimetic approach of N-cadherin in modulating fibroblast growth factor receptor signaling for corneal endothelial regeneration[J].FASEB J,2020,34(9):11698-11713.DOI:10.1096/fj.201902525RR.
[63] 刘忆南,蔡宏媛,洪晶,等. 重组牛碱性成纤维细胞生长因子对角膜内皮细胞密度低下患者白内障术后角膜内皮的保护作用[J]. 眼科新进展,2023,43(6):467-471.DOI:10.13389/j.cnki.rao.202 3.0094.
[64] 郭会越,王桂芳,林赓. 重组人表皮生长因子滴眼液治疗电光性眼炎的疗效及对角膜内皮细胞的影响[J]. 中国工业医学杂志,2020,33(5):416-418.DOI:10.13631/j.cnki.zggyyx.2020.05.009.
[65] 赵杰琼,田蕴霖. 重组人表皮生长因子衍生物滴眼液联合玻璃酸钠滴眼液对白内障术后干眼症患者氧化应激指标及角膜内皮细胞功能的影响[J]. 临床医学研究与实践,2023,8(12):57-60.DOI:10.19347/j.cnki.2096-1413.202312016.
[66] 阮明辉,黄婷婷,李学蕊,等. 眼部湿化氧疗对高原地区硬核白内障超声乳化术后角膜水肿的疗效研究[J]. 现代医药卫生,2023,39(13):2222-2227.DOI:10.3969/j.issn.1009- 5519.2023.13.013.
[67] Shin H, Min JK, Kim NR, et al. Effects of Y-27632, a rho-associated kinase inhibitor, on human corneal endothelial cells cultured by isolating human corneal endothelial progenitor cells[J].Korean J Ophthalmol,2023,37(1):31-41.DOI:10.3341/kjo.2022.0133.
[68] Okumura N, Sakamoto Y, Fujii K, et al. Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction[J].Sci Rep,2016,6:26113.DOI:10.1038/srep26113.
[69] Garnock-Jones KP. Ripasudil: first global approval[J].Drugs,2014,74(18):2211-2215.DOI:10.1007/s40265-014-0333-2.
[70] Okumura N, Okazaki Y, Inoue R, et al. Effect of the rho-associated kinase inhibitor eye drop (ripasudil) on corneal endothelial wound healing[J].Invest Ophthalmol Vis Sci,2016,57(3):1284-1292.DOI:10.1167/iovs.15-18586.
[71] Alkharashi M, AlAbbasi O, Magliyah M. Perioperative use of rho-kinase inhibitors has beneficial effect on corneal endothelium after phacoemulsification[J].Middle East Afr J Ophthalmol,2020,26(4):246-249.DOI:10.4103/meajo.MEAJO_27_19.